Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículo Destacado en trastornos del movimiento

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Enfermedad de Parkinson

2053 ARTíCULOS , VIENDO DEL 106 AL 120

PUBMED

The neuroprotective and antidiabetic effects of trigonelline: A review of signaling pathways and molecular mechanisms

Liang Y, Dai X, Cao Y, Wang X, Lu J, Xie L, Liu K, Li X.

Biochimie. 2022 Oct 15:S0300-9084(22)00274-7. doi: 10.1016/j.biochi.2022.10.009. Online ahead of print.

0

0

0

PUBMED

Role of mitophagy in the neurodegenerative diseases and its pharmacological advances: A review

Wang Q, Xue H, Yue Y, Hao S, Huang SH, Zhang Z.

Front Mol Neurosci. 2022 Oct 4;15:1014251. doi: 10.3389/fnmol.2022.1014251. eCollection 2022.

0

0

0

PUBMED

Role of TREM2 in the Development of Neurodegenerative Diseases After Traumatic Brain Injury

Zhang C, Chen S.

Mol Neurobiol. 2022 Oct 20. doi: 10.1007/s12035-022-03094-w. Online ahead of print.

0

0

0

PUBMED

Dementia with Lewy bodies: Impact of co-pathologies and implications for clinical trial design

Toledo JB, Abdelnour C, Weil RS, Ferreira D, Rodriguez-Porcel F, Pilotto A, Wyman-Chick KA, Grothe MJ, Kane JPM, Taylor A, Rongve A, Scholz S, Leverenz JB, Boeve BF, Aarsland D, McKeith IG, Lewis S, L

Alzheimers Dement. 2022 Oct 14. doi: 10.1002/alz.12814. Online ahead of print.

0

0

0

PUBMED

Prescribing cascades in community-dwelling adults: A systematic review

Doherty AS, Shahid F, Moriarty F, Boland F, Clyne B, Dreischulte T, Fahey T, Kennelly SP, Wallace E.

Pharmacol Res Perspect. 2022 Oct;10(5):e01008. doi: 10.1002/prp2.1008.

0

0

0

PUBMED

Dendritic involvement in inhibition and disinhibition of vulnerable dopaminergic neurons in healthy and pathological conditions

Evans RC.

Neurobiol Dis. 2022 Oct 1;172:105815. doi: 10.1016/j.nbd.2022.105815. Epub 2022 Jul 9.

0

0

0

PUBMED

Direct Cell Conversion of Somatic Cells into Dopamine Neurons: Achievements and Perspectives

Aversano S, Palladino R, Caiazzo M.

Cell Reprogram. 2022 Oct;24(5):259-270. doi: 10.1089/cell.2022.0065. Epub 2022 Sep 22.

0

0

0

PUBMED

Study in Parkinson's disease of exercise phase 3 (SPARX3): study protocol for a randomized controlled trial

Patterson CG, Joslin E, Gil AB, Spigle W, Nemet T, Chahine L, Christiansen CL, Melanson E, Kohrt WM, Mancini M, Josbeno D, Balfany K, Griffith G, Dunlap MK, Lamotte G, Suttman E, Larson D, Branson C,

Trials. 2022 Oct 6;23(1):855. doi: 10.1186/s13063-022-06703-0.

0

0

0

PUBMED

The Prephase Nursing in Levodopa Carbidopa Intestinal Gel Therapy

Lezzi P, Lupo R, Lezzi T, Vitale E.

J Neurosci Nurs. 2022 Oct 1;54(5):215-219. doi: 10.1097/JNN.0000000000000671. Epub 2022 Jul 15.

0

0

0

PUBMED

Exploring the Connection Between the Gut Microbiome and Parkinson's Disease Symptom Progression and Pathology: Implications for Supplementary Treatment Options

Chan DG, Ventura K, Villeneuve A, Du Bois P, Holahan MR.

J Parkinsons Dis. 2022 Oct 17. doi: 10.3233/JPD-223461. Online ahead of print.

0

0

0

PUBMED

Systematic review and meta-analysis of randomised controlled trials on the effects of yoga in people with Parkinson's disease

Suárez-Iglesias D, Santos L, Sanchez-Lastra MA, Ayán C.

Disabil Rehabil. 2022 Oct;44(21):6210-6229. doi: 10.1080/09638288.2021.1966522. Epub 2021 Sep 17.

0

0

0

PUBMED

Retinal organoids from human-induced pluripotent stem cells: From studying retinal dystrophies to early diagnosis of Alzheimer's and Parkinson's disease

Móvio MI, de Lima-Vasconcellos TH, Dos Santos GB, Echeverry MB, Colombo E, Mattos LS, Resende RR, Kihara AH.

Semin Cell Dev Biol. 2022 Oct 6:S1084-9521(22)00273-7. doi: 10.1016/j.semcdb.2022.09.011. Online ahead of print.

0

0

0

PUBMED

Why do 'OFF' periods still occur during continuous drug delivery in Parkinson's disease?

Rota S, Urso D, van Wamelen DJ, Leta V, Boura I, Odin P, Espay AJ, Jenner P, Chaudhuri KR.

Transl Neurodegener. 2022 Oct 13;11(1):43. doi: 10.1186/s40035-022-00317-x.

0

0

0

PUBMED

Disease Modeling of Neurodegenerative Disorders Using Direct Neural Reprogramming

Legault EM, Bouquety J, Drouin-Ouellet J.

Cell Reprogram. 2022 Oct;24(5):228-251. doi: 10.1089/cell.2021.0172. Epub 2022 Jun 24.

0

0

0

PUBMED

Crosstalk between neurological, cardiovascular, and lifestyle disorders: insulin and lipoproteins in the lead role

Tyagi R, Vaidya B, Sharma SS.

Pharmacol Rep. 2022 Oct;74(5):790-817. doi: 10.1007/s43440-022-00417-5. Epub 2022 Sep 23.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy